Sirkar K K
Chemical Engineering, Chemistry and Environmental Sciences, Center for Membrane Technologies, New Jersey Institute of Technology, Newark, NJ 07102, USA.
Curr Opin Drug Discov Devel. 2000 Nov;3(6):714-22.
Membrane technologies are increasingly becoming useful components of pharmaceutical production processes. For some time, membrane separation technologies of reverse osmosis, ultrafiltration and microfiltration have been used to concentrate and purify both small and large molecules. More recent applications of membrane technologies cover a broad range of separation, concentration and purification needs. For example, pharmaceutical waste streams can be treated by nanofiltration or pervaporation to detoxify them and/or reduce the volume of waste requiring incineration. Solvent vapors can be removed/recovered from nitrogen/air emission by vapor permeation. Enantiomeric/ other isomeric mixtures can be separated by liquid membranes or membrane-based multi-phase extractive enzymatic resolution. Nanofiltration or pervaporation can be used to enhance synthesis reaction conversion. High performance tangential flow filtration can be used to fractionate protein mixtures whose molecular used to integrate clarification and chromatographic processes for downstream processing of biomolecules. This review attempts to provide a perspective of these developments in laboratories, pilot plants and commercial applications.
膜技术正日益成为药物生产过程中的有用组成部分。一段时间以来,反渗透、超滤和微滤等膜分离技术已被用于浓缩和纯化小分子和大分子。膜技术的最新应用涵盖了广泛的分离、浓缩和纯化需求。例如,药物废物流可以通过纳滤或渗透汽化进行处理,以使其解毒和/或减少需要焚烧的废物量。溶剂蒸汽可以通过蒸汽渗透从氮气/空气排放中去除/回收。对映体/其他异构体混合物可以通过液膜或基于膜的多相萃取酶解来分离。纳滤或渗透汽化可用于提高合成反应转化率。高性能切向流过滤可用于分离蛋白质混合物,其分子用于整合生物分子下游加工的澄清和色谱过程。本综述试图提供这些在实验室、中试工厂和商业应用中的发展情况的视角。